Market Overview:
The global cardiac safety services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing number of clinical trials and rising demand for cardiac safety services from pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), and others. The global cardiac safety services market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into integrated services and standalone services. Integrated services are further sub-segmented into comprehensive service packages and modular service packages. Standalone services are further sub-segmented into feasibility studies, pharmacovigilance (PV), risk management plans (RMPs), data management & analysis, medical writing & regulatory affairs consulting (MWRA),and others). On the basis of application, the market is segmented into pharmaceuticals companies, CROs,, medical device manufacturers,, contract manufacturing organizations(CMOs)&biotech companies,. Pharmaceuticals companies accounted for a major share in 2017 owing to rising demand for cardiac safety assessment from this sector across regions. CROs are expected to witness highest growth during forecast period due to increasing number of outsourcing agreements by pharma/biotech firms for conducting clinical trials globally. Medical device manufacturers accounted for second largest share in 2017 due high prevalence rateof cardiovascular diseasesand growing awareness about benefits associated with early diagnosis.
Product Definition:
Cardiac Safety Services is a term that refers to the various services and treatments that are used to protect the heart during surgery. These services can include things like cardiac monitoring, medications, and specialized equipment. The importance of cardiac safety services varies depending on the procedure being performed, but they can be critical in preventing serious complications or death.
Integrated Services:
Integrated services is a combination of telemedicine and traditional medical care. Integrated services can be used in various applications such as cardiac surgery, remote patient monitoring, chronic disease management & rehabilitation or home health care. The service includes consultation from the specialist via video conferencing followed by the treatment to the patient at their convenience.
Standalone Services:
Cardiac safety services are provided in a healthcare facility by medical and nursing staff with the help of EMR/EHR, telemedicine, and other standalone systems. Standalone systems are used to store patient information which can be accessed easily during emergencies such as cardiac arrest. The system is also helpful for regular checkups where the data helps doctors analyze patients’ conditions better.
Application Insights:
The others application segment accounted for the largest revenue share in 2017 and is anticipated to grow at a significant rate over the forecast period. The services include those provided by companies that provide equipment, laboratory or other support functions. These companies offer safety services to their customers across various applications such as clinical testing, quality assurance & control, and patient management information systems.
The pharmaceutical and biopharmaceuticals companies segment is expected to register a lucrative CAGR of XX% from 2018 to 2030 owing to an increase in R&D activities coupled with an increasing number of drug launches worldwide. This has led to an increased need for research involving human participants which requires a robust set of safety protocols followed by CROs worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies and favorable government initiatives. For instance, Cardiometabolic Research Clinic (CRCT) is a research network that comprises over 100 clinical research sites across North America. The network aims to study the causes and treatments of heart diseases by conducting various studies on patients with different conditions such as obesity, diabetes etc. Thus, such initiatives are expected to boost growth in this region during the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as increasing healthcare expenditure and awareness about emerging technologies for cardiac safety services among end-users including hospitals & clinics.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing demand for cardiac safety services in emerging countries
- Rising awareness about the importance of cardiac safety services
- Technological advancements in the field of cardiac safety services
- Growing number of clinical studies on cardiac safety
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Safety Services Market Research Report
By Type
Integrated Services, Standalone Services
By Application
Pharmaceutical and Biopharmaceuticals Companies, Contract Research Organization(CRO), Others
By Companies
Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Ncardia AG, Richmond Pharmacology, PhysioStim, IQVIA, BioTelemetry, Inc, Pharmaceutical Product Development, LLC, Shanghai Medicilon Inc, SGS SA, Spaulding Clinical Research, LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Safety Services Market Report Segments:
The global Cardiac Safety Services market is segmented on the basis of:
Types
Integrated Services, Standalone Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biopharmaceuticals Companies, Contract Research Organization(CRO), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biotrial
- Banook Group
- Bioclinica
- Certara L.P.
- Celerion, Inc
- ERT, Inc
- Laboratory Corporation of America Holdings
- Medpace Holdings, Inc.
- Ncardia AG
- Richmond Pharmacology
- PhysioStim
- IQVIA
- BioTelemetry, Inc
- Pharmaceutical Product Development, LLC
- Shanghai Medicilon Inc
- SGS SA
- Spaulding Clinical Research, LLC
Highlights of The Cardiac Safety Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Integrated Services
- Standalone Services
- By Application:
- Pharmaceutical and Biopharmaceuticals Companies
- Contract Research Organization(CRO)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Safety Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac safety services are a group of health care professionals who work together to ensure that patients with heart disease receive the best possible care. Cardiac safety services may include nurses, doctors, cardiac technicians, and others. They help to identify and monitor patients with heart disease, provide education and support, and make sure that they receive the best possible treatment.
Some of the key players operating in the cardiac safety services market are Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Ncardia AG, Richmond Pharmacology, PhysioStim, IQVIA, BioTelemetry, Inc, Pharmaceutical Product Development, LLC, Shanghai Medicilon Inc, SGS SA, Spaulding Clinical Research, LLC.
The cardiac safety services market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Safety Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Safety Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Safety Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Safety Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Safety Services Market Size & Forecast, 2018-2028
4.5.1 Cardiac Safety Services Market Size and Y-o-Y Growth
4.5.2 Cardiac Safety Services Market Absolute $ Opportunity
Chapter 5 Global Cardiac Safety Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiac Safety Services Market Size Forecast by Type
5.2.1 Integrated Services
5.2.2 Standalone Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiac Safety Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiac Safety Services Market Size Forecast by Applications
6.2.1 Pharmaceutical and Biopharmaceuticals Companies
6.2.2 Contract Research Organization(CRO)
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Safety Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Safety Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiac Safety Services Analysis and Forecast
9.1 Introduction
9.2 North America Cardiac Safety Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiac Safety Services Market Size Forecast by Type
9.6.1 Integrated Services
9.6.2 Standalone Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiac Safety Services Market Size Forecast by Applications
9.10.1 Pharmaceutical and Biopharmaceuticals Companies
9.10.2 Contract Research Organization(CRO)
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiac Safety Services Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiac Safety Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiac Safety Services Market Size Forecast by Type
10.6.1 Integrated Services
10.6.2 Standalone Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiac Safety Services Market Size Forecast by Applications
10.10.1 Pharmaceutical and Biopharmaceuticals Companies
10.10.2 Contract Research Organization(CRO)
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiac Safety Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiac Safety Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiac Safety Services Market Size Forecast by Type
11.6.1 Integrated Services
11.6.2 Standalone Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiac Safety Services Market Size Forecast by Applications
11.10.1 Pharmaceutical and Biopharmaceuticals Companies
11.10.2 Contract Research Organization(CRO)
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiac Safety Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiac Safety Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiac Safety Services Market Size Forecast by Type
12.6.1 Integrated Services
12.6.2 Standalone Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiac Safety Services Market Size Forecast by Applications
12.10.1 Pharmaceutical and Biopharmaceuticals Companies
12.10.2 Contract Research Organization(CRO)
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiac Safety Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiac Safety Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiac Safety Services Market Size Forecast by Type
13.6.1 Integrated Services
13.6.2 Standalone Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiac Safety Services Market Size Forecast by Applications
13.10.1 Pharmaceutical and Biopharmaceuticals Companies
13.10.2 Contract Research Organization(CRO)
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Safety Services Market: Competitive Dashboard
14.2 Global Cardiac Safety Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biotrial
14.3.2 Banook Group
14.3.3 Bioclinica
14.3.4 Certara L.P.
14.3.5 Celerion, Inc
14.3.6 ERT, Inc
14.3.7 Laboratory Corporation of America Holdings
14.3.8 Medpace Holdings, Inc.
14.3.9 Ncardia AG
14.3.10 Richmond Pharmacology
14.3.11 PhysioStim
14.3.12 IQVIA
14.3.13 BioTelemetry, Inc
14.3.14 Pharmaceutical Product Development, LLC
14.3.15 Shanghai Medicilon Inc
14.3.16 SGS SA
14.3.17 Spaulding Clinical Research, LLC
